The global landscape of neoadjuvant and adjuvant anti-PD-1/PD-L1 clinical trials

The neoadjuvant and adjuvant anti-PD-1/PD-L1 treatment has been increasingly noticed. To summarize the global landscape of these clinical trials will provide essential data for all the stakeholders of drug dev...

Source: Journal of Hematology and Oncology - February 8, 2022 Category: Hematology Authors: Dawei Wu, Huiyao Huang, Minghui Zhang, Ziwei Li, Shuhang Wang, Yue Yu, Yuan Fang, Ning Jiang, Huilei Miao, Peiwen Ma, Yu Tang and Ning Li Tags: Letter to the Editor Source Type: research